Company / Profit Margin
Merck & Co. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
28.1%
FY2025
5-year range
0.6% / 28.1%
FY2021-FY2025
Trend
+5.2%
vs FY2024
Sector context
#23 of 146
Health Care
What the data says
Merck & Co.'s profit margin of 28.1% is higher than 84% of companies in the Health Care sector (FY2025). Profit Margin has fluctuated over the past 10 years, ranging from 0.6% in FY2023 to 28.1% in FY2025.
Based on SEC 10-K filings.
28.1% in FY2025 with a 5-year CAGR of +11.1%. Top quartile in the Health Care sector.
Improved from 0.6% to 28.1% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +3.6pp
- 5-Year Change
- +11.1pp
- 10-Year Change
- -
Sector benchmark
Top 16% in Health CareTop 16% of 146This company 28.1% Sector average -796.3%
▼
+103.5% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 5.2% year-over-year.
- Currently 824.4pp above the Health Care sector average.
- Lowest profit margin in the period was in FY2023.
Company context
Key Data Points
- Strong profit margin: 29.6%
- Strong return on equity: 36.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 28.1% | +5.2% |
| FY2024 | 26.7% | +4273.8% |
| FY2023 | 0.6% | -97.5% |
| FY2022 | 24.5% | -8.6% |
| FY2021 | 26.8% | +57.4% |
| FY2020 | 17.0% | -32.4% |
| FY2019 | 25.2% | +71.0% |
| FY2018 | 14.7% | +146.4% |
| FY2017 | 6.0% | -39.4% |
| FY2016 | 9.8% | -12.4% |
As of FY2025 · SEC 10-K · Updated Mar 9, 2026